Page last updated: 2024-08-24

fluorodeoxyglucose f18 and leflunomide

fluorodeoxyglucose f18 has been researched along with leflunomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG1
Alibaz-Oner, F; Aydin, SZ; Direskeneli, H1
Dasgupta, B; Kayani, A; Sebastian, A1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and leflunomide

ArticleYear
Advances in the diagnosis, assessment and outcome of Takayasu's arteritis.
    Clinical rheumatology, 2013, Volume: 32, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Fluorodeoxyglucose F18; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Angiography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Takayasu Arteritis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor-alpha

2013

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and leflunomide

ArticleYear
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
    Journal of neuro-oncology, 2000, Volume: 46, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome

2000
Excellent Response to Leflunomide in a Case of Large-Vessel Giant Cell Arteritis Demonstrated Simultaneously by Clinical, Laboratory, Ultrasound, and Positron Emission Tomography/Computed Tomography Parameters.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Oct-01, Volume: 27, Issue:7

    Topics: Aged; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Laboratories; Leflunomide; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis

2021